Boosting the body's endocannabinoid system to relieve headaches
Targeting the Endocannabinoid System for Headache Intervention
['FUNDING_R01'] · UNIVERSITY OF ARIZONA · NIH-11258034
Researchers are trying to increase natural endocannabinoid levels to reduce migraine and medication-overuse headaches in men and women.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF ARIZONA (nih funded) |
| Locations | 1 site (TUCSON, UNITED STATES) |
| Trial ID | NIH-11258034 on ClinicalTrials.gov |
What this research studies
This project uses rat models to learn how the brain's endocannabinoid system may drive migraine and medication-overuse headaches. The team measures levels of the natural cannabinoid 2-AG and studies enzymes (ABHD6 and MAGL) that break it down in a pain-regulating brain region called the PAG. They compare male and female animals because early results suggest women may lose 2-AG more readily and show worse headache signals. The goal is to see whether preventing 2-AG breakdown can lower inflammation and headache-related responses and guide new treatment approaches.
Who could benefit from this research
Good fit: People with frequent migraine or medication-overuse headaches, both men and women, would be the likely candidates for therapies this work aims to help.
Not a fit: Patients whose headaches come from structural causes, non–endocannabinoid mechanisms, or who cannot use cannabinoid-related therapies may not benefit from this approach.
Why it matters
Potential benefit: If successful, this work could lead to treatments that boost the body's own cannabinoid signals to reduce headache frequency and severity with fewer side effects than some current drugs.
How similar studies have performed: There are clinical observations and early lab findings suggesting endocannabinoid boosting might help migraine, but direct therapeutic success in people is still limited and largely experimental.
Where this research is happening
TUCSON, UNITED STATES
- UNIVERSITY OF ARIZONA — TUCSON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MILNES, TALLY MARIE — UNIVERSITY OF ARIZONA
- Study coordinator: MILNES, TALLY MARIE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.